JB

Jane Bell

Mesoblast Limited | Non-Executive Director
Ms. Bell is a banking and finance lawyer with 30 years experience in international law firms, financial services and corporate treasury operations focusing on international investment transactions in the United States, Canada, Australia and the United Kingdom. She has served as a non executive Director in a diverse range of highly regulated sectors including delivery of healthcare, life sciences, medical research, and funds management.

Companies and Roles

Company
Title
Tenure
Since
MSB
MSB
Mesoblast Limited
  • Non-Executive Director
1yrs, 8mthAug 2022
ATX
ATX
Amplia Therapeutics Limited
  • Non-Executive Director
3yrsApr 2021

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
MSB
MSB
Mesoblast Limited
12/04/24N/A543,441526,729N/A
ATX
ATX
Amplia Therapeutics Limited
31/12/232,025,474N/A535,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
MSB
MSB
Mesoblast Limited
12/04/24
Buy
233,918$0.855$199,999On-market trade
MSB
MSB
Mesoblast Limited
10/01/24
Issued
326,729$0.285$93,117Issue of options
MSB
MSB
Mesoblast Limited
28/12/23
Issued
61,905$0.300$18,571Rights issue
MSB
MSB
Mesoblast Limited
16/01/23
Issued
200,000$0.975$195,000Issue of options
MSB
MSB
Mesoblast Limited
07/09/22
Buy
133,333$0.825$109,999On-market trade